Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19
Status
Conditions
Details and patient eligibility
About
The SARS-CoV 2 pandemic started in China in December 2019, then reached France on January 24, 2020.
On March 14, France moved into phase 3 of the epidemic threshold with the implementation of containment measures on March 17 Measures were put in place by N.Belloubet (French Minister of Justice) from March 17, including suspension of visiting rooms and activities in detention.
Containment provides boredom and isolation with many potential consequences: sleep disturbance, anxiety, PTSD, depression, suicide, addictive behavior and violence.
However,prisoners have a higher prevalence of substance use disorders than the general population.
What will have been the impact of the confinement on the consumption of psychoactive substances by prisoners at the Villeneuve Les Maguelone prison.
- Anonymous questionnaire from the start
- Collection of socio-demographic data
- Collection of consumption data before and during containment
- Collection of monitoring data
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Men incarcerated at Villeneuve Les Maguelone prison
- On a given date (May 12)
- Major
- French speaking
- non illiterate
Exclusion criteria
- minors
- patients refusing
- non-French speaking
- illiterate
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal